Exagen Inc. (XGN) Shareholders’ equity 2018–2025
Exagen Inc. (XGN) shareholders’ equity at each fiscal year-end, per SEC filings.
$17.4MFY2025 · since FY2018: -$112.0M → $17.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.4M | +82.9% |
| FY2024 | $9.5M | -58.0% |
| FY2023 | $22.7M | -46.6% |
| FY2022 | $42.5M | -50.0% |
| FY2021 | $84.9M | +103.0% |
| FY2020 | $41.8M | -24.8% |
| FY2019 | $55.7M | +149.7% |
| FY2018 | -$112.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice